These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35482721)

  • 21. Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study.
    Marfo K; Dei-Adomakoh Y; Segbefia C; Dwomoh D; Edgal A; Ampah N; Ramachandrachar BC; Subramanyam K; Natarajan A; Egbujo O; Ataga KI
    BMC Health Serv Res; 2023 Sep; 23(1):1018. PubMed ID: 37735428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
    Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
    Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The controversial role of red cell transfusions for sickle cell pain.
    Karafin MS; Field JJ
    Curr Opin Hematol; 2019 Nov; 26(6):442-447. PubMed ID: 31567433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.
    Singh A; Sontag MK; Zhou M; Dasgupta M; Crume T; McLemore M; Galadanci N; Randall E; Steiner N; Brandow AM; Koch K; Field JJ; Hassell K; Snyder AB; Kanter J
    JMIR Public Health Surveill; 2023 Jun; 9():e42816. PubMed ID: 37379070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.
    Valle J; Lebensburger JD; Garimella PS; Gopal S
    JMIR Public Health Surveill; 2024 Jul; 10():e57290. PubMed ID: 39008353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance.
    Johnson KM; Jiao B; Ramsey SD; Bender MA; Devine B; Basu A
    Blood Adv; 2023 Feb; 7(3):365-374. PubMed ID: 35575558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study.
    Shah N; Bhor M; Xie L; Halloway R; Arcona S; Paulose J; Yuce H
    Health Qual Life Outcomes; 2019 Oct; 17(1):155. PubMed ID: 31619251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structuring a conceptual model for cost-effectiveness analysis of frailty interventions.
    Haji Ali Afzali H; Karnon J; Theou O; Beilby J; Cesari M; Visvanathan R
    PLoS One; 2019; 14(9):e0222049. PubMed ID: 31509563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America.
    Winn A; Basu A; Ramsey SD
    Pharmacoecon Open; 2023 Mar; 7(2):313-320. PubMed ID: 36773220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, treatment, and outcomes of renal conditions in pediatric sickle cell disease.
    Stallworth JR; Tripathi A; Jerrell JM
    South Med J; 2011 Nov; 104(11):752-6. PubMed ID: 22024785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD).
    Mupfudze TG; Preussler JM; Sees JA; SanCartier M; Arnold SD; Devine S
    Transplant Cell Ther; 2021 Apr; 27(4):345-351. PubMed ID: 33836889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature.
    Jiao B; Basu A; Roth J; Bender M; Rovira I; Clemons T; Quach D; Ramsey S; Devine B
    Pharmacoeconomics; 2021 Nov; 39(11):1225-1241. PubMed ID: 34368937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
    Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
    Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Pain: Prevalence and Management.
    Carroll CP; Brandow AM
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1151-1165. PubMed ID: 36400536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.
    Brandow AM; Carroll CP; Creary S; Edwards-Elliott R; Glassberg J; Hurley RW; Kutlar A; Seisa M; Stinson J; Strouse JJ; Yusuf F; Zempsky W; Lang E
    Blood Adv; 2020 Jun; 4(12):2656-2701. PubMed ID: 32559294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.